Testicular cancer is a curable cancer. The success of physicians in curing the disease is
underpinned by multidisciplinary advances. Cisplatin-based combination chemotherapy and …

Testicular germ cell tumors (TGCTs) and sex cord-stromal tumors (SCSTs) are the most
common testicular neoplasms. The morphological spectrum of such tumors is wide, with …

Purpose: Surveillance of clinical stage I (CSI) testicular germ cell tumors (GCT) is hampered
by low sensitivity and specificity of current biomarkers for detecting relapses. This study …

PURPOSE Approximately 20% of patients with clinical stage I seminoma relapse. Tumor
size and rete testis invasion have been identified as risk factors for relapse. However, the …

Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) is a novel molecularly-
targeted therapy that induces rapid cancer cell death by systemically administering an …

Simple Summary The size of the tumour is of clinical relevance in testicular tumours. Our
statistical analysis of 641 cases with testicular tumours revealed that 50% of cases with …

Simple Summary Testicular cancer (TC) is an uncommon group of tumors affecting
predominantly younger males between 15 and 40 years, and accounting for less than 1% of …

Simple Summary This review describes that miR371 is much more sensitive and specific
than the classical serum biomarkers of testicular germ cell cancer. There is a huge potential …

Background Active surveillance after orchiectomy is the preferred management in clinical
stage I (CSI) germ-cell tumours (GCT) associated with a 15 to 30% relapse rate. Patients …

Testicular cancer is the most common solid neoplasm of adult men between the ages of 20
and 40 years. Germ cell tumors account for 95% of all testicular tumors. The assessment of …